Renee Smith has over 25 years of experience in research and healthcare. Renee currently holds the role of Head, Early Development Capabilities and Alliances in the Oncology Therapeutic Area at Johnson & Johnson (J&J) Innovation Medicines. Prior to J&J, Renee served as Associate Vice President of Global Quality and Education at Sarah Cannon. Her experience with clinical trials spans from developing and implementing quality and educational programs for investigative sites and CRO operations to working in a large pharma where she established an oncology investigative site partnership program. Her unique perspective provides a good understanding of challenges across clinical research stakeholders. Renee serves as a member of the AACI corporate roundtable representing J&J, she has previously served as a Council Member on the American Society of Clinical Oncology (ASCO) Research Community Forum (RCF) as well as participated in several ASCO working groups. She has participated in research focused working groups with the Clinical Trials Transformation Initiative and the National Academies of Sciences, Engineering and Medicine. She has participated on the Society of Clinical Research Sites (SCRS) planning committee for the Oncology SCRS Oncology Summit for several of their annual meetings.
